infected human cells and with reprogrammed nave CTLs into which the HIV-recognizing T-cell receptor genes had been inserted using the lentiviral delivery system. One week later, when the researchers looked for HIV-infected human cells in the animals, they found that the infected cells had virtually been eliminated.
Dr. Goldstein notes that this study was done using genes for just a single CTL T-cell receptor. To make this strategy even more effective, were now in the process of isolating a cocktail of CTL receptor genes that are specific for many different HIV peptidesan approach analogous to todays combination drug therapy for treating HIV infection, says Dr. Goldstein. Ultimately, wed like to remove CTLs from patients, convert them into potent HIV-specific CTLs by inserting a variety of HIV-specific CTL receptor genes, and then re-infuse these fresh, genetically reprogrammed CTLs back into patients. By reinforcing the immune system in this way, we hope to turn the tide of battle against HIV in favor of people infected with the virus.
'/>"/>
Page: 1 2 3 Related medicine news :1.
Einstein researchers discover gene mutations linked to longer lifespans2.
Einstein honors Dr. Stanley Nathenson with Marshall S. Horwitz Faculty Prize for Research Excellence3.
Johnson City Medical Center Begins Offering Einstein Bros. Menu Items at Second On Campus Location4.
Sens. Kerry, Boxer and Feinstein call on FDA to Establish Maximum Level for Lead in Lipstick5.
Testing delays cause severe AIDS complications, Einstein researchers find6.
Einstein scientists treat cancer as an infectious disease -- with promising results7.
Albert Einstein Healthcare Network Turns to InterviewDirect to Qualify Job Candidates8.
NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity9.
Researchers control growth rate of replacement blood vessels, tissues10.
New protein discovery helps researchers understand autoimmune diseases11.
UF researchers warn parents about dangers of childhood foot burns